Hiroyoshi Yokoi Selected Research

Coronary Artery Bypass (Coronary Artery Bypass Surgery)

1/2015	Impact of Arterial Access Route on Bleeding Complications in Japanese Patients Undergoing Percutaneous Coronary Intervention- Insight From the PRASFIT Trial.
1/2014	Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study.
1/2014	Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention.
1/2012	Ratio of serum n-3 to n-6 polyunsaturated fatty acids and the incidence of major adverse cardiac events in patients undergoing percutaneous coronary intervention.
2/2008	[Long-term clinical follow-up after rotational atherectomy to coronary arterial stenosis in kawasaki disease].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroyoshi Yokoi Research Topics

Disease

33	Myocardial Infarction 01/2022 - 02/2007
25	Thrombosis (Thrombus) 11/2021 - 06/2009
24	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 06/2002
23	Hemorrhage 07/2022 - 06/2011
17	Acute Coronary Syndrome 07/2022 - 11/2011
17	Coronary Artery Disease (Coronary Atherosclerosis) 11/2020 - 03/2005
12	Peripheral Arterial Disease 01/2022 - 10/2014
9	Death (Near-Death Experience) 01/2018 - 07/2005
7	Stroke (Strokes) 06/2022 - 01/2009
7	Diabetes Mellitus 04/2016 - 11/2010
6	Pathologic Constriction (Stenosis) 02/2020 - 01/2011
6	Atherosclerosis 01/2014 - 04/2010
4	Ischemic Stroke 06/2022 - 01/2014
4	Cardiogenic Shock 01/2022 - 11/2004
4	Heart Failure 02/2021 - 02/2013
4	Chronic Limb-Threatening Ischemia 09/2015 - 03/2010
3	Atrial Fibrillation 07/2022 - 01/2022
3	ST Elevation Myocardial Infarction 01/2022 - 01/2012
3	Body Weight (Weight, Body) 02/2021 - 01/2015
3	Myocardial Ischemia (Ischemic Heart Diseases) 06/2013 - 07/2005
2	COVID-19 04/2022 - 11/2020
2	Hypertension (High Blood Pressure) 01/2022 - 01/2012
2	Vascular Diseases (Vascular Disease) 01/2022 - 02/2011
2	Renal Insufficiency (Renal Failure) 01/2022 - 09/2014
2	Ischemia 12/2021 - 04/2010
2	Type 2 Diabetes Mellitus (MODY) 11/2021 - 09/2018
2	Hyperlipidemias (Hyperlipidemia) 11/2021 - 08/2005
2	AIDS-Related Complex (ARC) 02/2021 - 11/2010
2	Venous Thromboembolism 01/2021 - 10/2020
2	Anemia 12/2020 - 07/2019
2	Coronary Stenosis (Coronary Artery Stenosis) 01/2018 - 11/2014
2	Ventricular Tachycardia 12/2016 - 02/2015
2	Sleep Apnea Syndromes (Sleep Apnea) 01/2016 - 11/2011
2	Wounds and Injuries (Trauma) 09/2015 - 06/2011
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2014 - 06/2011
2	Stable Angina 05/2013 - 01/2012
2	Atherosclerotic Plaque (Atheroma) 02/2012 - 08/2005
2	Hypercholesterolemia 01/2012 - 04/2010
2	Intermittent Claudication 08/2010 - 01/2009
1	Cerebral Infarction 07/2022
1	Non-ST Elevated Myocardial Infarction 01/2022
1	Chronic Renal Insufficiency 12/2020
1	Pulmonary Embolism 10/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2020
1	Coronary Disease (Coronary Heart Disease) 03/2020
1	Heart Arrest (Cardiac Arrest) 01/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2017
1	Infections 08/2016

Drug/Important Bio-Agent (IBA)

23	omega-Chloroacetophenone (Mace)IBA 10/2019 - 08/2010
16	Prasugrel Hydrochloride FDA Link 05/2022 - 05/2012
11	Clopidogrel (Plavix)FDA Link 01/2022 - 01/2012
10	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 07/2022 - 01/2013
6	LipidsIBA 11/2014 - 04/2010
5	Paclitaxel (Taxol)FDA LinkGeneric 11/2021 - 09/2014
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 08/2005
5	Rosuvastatin Calcium (Crestor)FDA Link 01/2014 - 04/2010
4	AnticoagulantsIBA 07/2022 - 12/2020
4	MetalsIBA 01/2022 - 02/2012
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2018 - 01/2009
4	oxidized low density lipoproteinIBA 01/2018 - 04/2010
4	Cilostazol (Pletal)FDA LinkGeneric 03/2017 - 01/2009
4	Sirolimus (Rapamycin)FDA Link 04/2015 - 01/2013
4	Pravastatin (Pravachol)FDA LinkGeneric 01/2013 - 08/2005
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 07/2014
3	LDL CholesterolIBA 01/2018 - 04/2010
3	Pharmaceutical PreparationsIBA 03/2017 - 01/2012
2	Heparin (Liquaemin)FDA LinkGeneric 12/2021 - 01/2017
2	RivaroxabanIBA 01/2021 - 10/2020
2	AdiponectinIBA 01/2014 - 11/2011
2	Purinergic P2Y Receptor AntagonistsIBA 01/2014 - 05/2012
2	CholesterolIBA 02/2012 - 08/2005
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	CreatinineIBA 07/2019
1	Warfarin (Coumadin)FDA LinkGeneric 01/2019
1	Pioglitazone (Actos)FDA Link 09/2018
1	thienopyridineIBA 08/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	pitavastatin (itavastatin)FDA Link 01/2018
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2017
1	CoagulaseIBA 08/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2016

Therapy/Procedure

44	Stents 06/2022 - 06/2002
37	Percutaneous Coronary Intervention 06/2022 - 01/2009
36	Therapeutics 06/2022 - 01/2009
18	Drug-Eluting Stents 01/2022 - 04/2010
6	Surgical Amputation (Amputations) 12/2021 - 01/2009
5	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2015 - 02/2008
4	Catheters 01/2022 - 06/2002
4	Renal Dialysis (Hemodialysis) 11/2021 - 01/2012
4	Secondary Prevention 09/2018 - 04/2010
3	Punctures 04/2017 - 07/2014
2	Limb Salvage 11/2017 - 03/2010
2	Catheter Ablation 12/2016 - 02/2015
2	Carotid Endarterectomy 07/2014 - 01/2013
1	Denervation 01/2022
1	Conservative Treatment 01/2022
1	Intra-Aortic Balloon Pumping 01/2022
1	Extracorporeal Membrane Oxygenation 01/2022
1	Myocardial Revascularization 01/2018
1	Lasers (Laser) 08/2016